chrX-48576411-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006743.5(RBM3):āc.308A>Gā(p.Tyr103Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,095,992 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 9/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006743.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM3 | NM_006743.5 | c.308A>G | p.Tyr103Cys | missense_variant | 4/7 | ENST00000376759.8 | NP_006734.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM3 | ENST00000376759.8 | c.308A>G | p.Tyr103Cys | missense_variant | 4/7 | 1 | NM_006743.5 | ENSP00000365950.3 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 110723Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33051 FAILED QC
GnomAD3 exomes AF: 0.0000508 AC: 9AN: 177169Hom.: 0 AF XY: 0.0000483 AC XY: 3AN XY: 62161
GnomAD4 exome AF: 0.0000164 AC: 18AN: 1095992Hom.: 0 Cov.: 32 AF XY: 0.0000194 AC XY: 7AN XY: 361492
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 110723Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33051
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.308A>G (p.Y103C) alteration is located in exon 4 (coding exon 3) of the RBM3 gene. This alteration results from a A to G substitution at nucleotide position 308, causing the tyrosine (Y) at amino acid position 103 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at